Circ-ZBTB38 as an oncogenic circular RNA: Mechanisms in disrupting RalGAP complexes and its clinical value in

Wanqi Zhang1, Nan Yang2, Yuekai Wang3

  • 1Department of Plastic & Cosmetic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China; Department of Teaching and Experimental Center, College of Basic Medical Sciences, Army Medical University (Third Military Medical University), Chongqing, 400038, China.

Abstract

Insights

Circular RNAs (circRNAs) like circ-ZBTB38 promote melanoma by degrading RALGAP B, disrupting Ral signaling. Targeting circ-ZBTB38 offers a new therapeutic strategy for melanoma patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer progression.
  • circRNAs have potential as diagnostic and therapeutic targets in various tumors.
  • The specific function of circ-ZBTB38 in melanoma remains largely unexplored.

Purpose of the Study:

  • To investigate the functional mechanism of circ-ZBTB38 in melanoma.
  • To explore the clinical application value of circ-ZBTB38 in melanoma.
  • To elucidate the circ-ZBTB38/RALGAPB regulatory axis in melanoma.

Main Methods:

  • Bioinformatic screening of differentially expressed circRNAs from the GSE138412 dataset.
  • Validation using circBase, qPCR, Sanger sequencing, and RNase R digestion.
  • Functional assays including gain- and loss-of-function experiments, proliferation, migration, and invasion assays.
  • Mechanistic studies involving RNA pull-down, mass spectrometry, RIP assays, ubiquitination assays, and western blotting.
  • In vivo studies using mouse models and clinical correlation analysis via tissue microarrays.

Main Results:

  • circ-ZBTB38 was identified as an oncogenic circRNA, significantly upregulated in melanoma tissues and cell lines.
  • circ-ZBTB38 overexpression promoted melanoma cell proliferation, migration, and invasion.
  • Mechanistically, circ-ZBTB38 binds to RALGAPB, promoting its ubiquitination and degradation, leading to hyperactivation of Ral signaling.
  • High circ-ZBTB38 expression correlated with poor prognosis in melanoma patients.
  • Inhibition of circ-ZBTB38 in vivo suppressed tumor growth, metastasis, and improved survival in mice.

Conclusions:

  • circ-ZBTB38 acts as an oncogene in melanoma by mediating RALGAPB post-translational degradation and activating Ral signaling.
  • The circ-ZBTB38/RALGAPB axis represents a novel regulatory circuit in melanoma.
  • circ-ZBTB38 is a potential prognostic biomarker and therapeutic target for melanoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K